Procter & Gamble (NYSE:PG) Stock Price Down 1.7% – What’s Next?

The Procter & Gamble Company (NYSE:PG)’s stock price fell 1.7% during trading on Monday . The stock traded as low as $161.31 and last traded at $162.32. 1,868,976 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 4,062,400 shares. The stock had previously closed at $165.13.

Analyst Ratings Changes

PG has been the topic of several analyst reports. DA Davidson reaffirmed a “buy” rating and set a $209.00 price target on shares of Procter & Gamble in a research note on Friday, December 27th. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a report on Monday, September 30th. Piper Sandler began coverage on Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price for the company. Finally, Wells Fargo & Company decreased their price target on shares of Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a research report on Tuesday. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus price target of $179.75.

Procter & Gamble Trading Up 0.5 %

The firm has a market capitalization of $381.68 billion, a price-to-earnings ratio of 27.94, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The firm’s 50 day moving average is $169.92 and its 200 day moving average is $169.75.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the prior year, the business posted $1.83 earnings per share. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. Equities analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the sale, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO R. Alexandra Keith sold 1,992 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares of the company’s stock, valued at approximately $2,343,110. The trade was a 12.63 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 75,439 shares of company stock worth $13,317,460. 0.18% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Procter & Gamble

Hedge funds have recently bought and sold shares of the business. Acorn Creek Capital LLC increased its holdings in shares of Procter & Gamble by 2.8% in the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock worth $376,000 after purchasing an additional 59 shares in the last quarter. Patrick M Sweeney & Associates Inc. boosted its position in shares of Procter & Gamble by 1.1% during the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after buying an additional 59 shares during the last quarter. Traveka Wealth LLC increased its holdings in Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock worth $616,000 after buying an additional 60 shares in the last quarter. Allen Mooney & Barnes Investment Advisors LLC raised its position in Procter & Gamble by 0.7% in the 3rd quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock worth $1,507,000 after buying an additional 61 shares during the last quarter. Finally, Valued Wealth Advisors LLC lifted its stake in Procter & Gamble by 11.2% during the 3rd quarter. Valued Wealth Advisors LLC now owns 605 shares of the company’s stock valued at $105,000 after acquiring an additional 61 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.